SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-000761
Filing Date
2020-01-10
Accepted
2020-01-10 16:17:05
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 clsd-s3.htm S-3 305404
2 EX-5.1 clsd-ex51_6.htm EX-5.1 11951
3 EX-23.1 clsd-ex231_19.htm EX-23.1 2349
4 GRAPHIC gqxvl45xtyu4000001.jpg GRAPHIC 3821
5 GRAPHIC grpj4vh0iezo000001.jpg GRAPHIC 28720
  Complete submission text file 0001564590-20-000761.txt   365818
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235880 | Film No.: 20521256
SIC: 2834 Pharmaceutical Preparations